Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Research finds tablet effective in slowing progression of Alzheimer’s disease over 18 months

April 10, 2025 Research and Development Alzheimer's disease, Neurology, TauRx Pharmaceutics, research and development

TauRx Pharmaceutics reports that hydromethylthionine mesylate (HMTM) could be an oral treatment for slowing the progression of Alzheimer’s disease over …
News

Infinitopes launches first-in-human trial of vaccine targeting oesophageal cancer

April 9, 2025 Research and Development Infinitopes, Oncology, biotech, oesophageal cancer, oncology

The cancer biotech company Infinitopes has gained approval by the UK Medicines and Healthcare products Regulatory Agency (MHRA) to evaluate …
News

Ipsen’s Iqirvo approved for use in NHS Scotland to treat rare liver disease

April 8, 2025 Research and Development R&D, Rare Diseases, Scottish Medicines Consortium, ipsen, primary biliary cholangitis (PBC)

The Scottish Medicines Consortium (SMC) has accepted the use of Ipsen’s Iqirvo (elafibranor) in NHS Scotland for the treatment of …
News

High Force Research appoints Nathalie Huther as chief commercial officer

April 8, 2025 Manufacturing and Production, Research and Development Corporate, High Force Research, cco, manufacturing and production

High Force Research has announced that it has appointed Nathalie Huther as its first chief commercial officer (CCO) following the …
Appointment

ELRIG appoints Del Trezise as chair

April 8, 2025 Research and Development ELRIG, Pharmacy, R&D, drug discovery, non-profit organisation, pharma

ELRIG, a non-profit volunteer-led organisation dedicated to the drug discovery community, has appointed Del Trezise as chair of the board. …
Appointment

Academy of Medical Sciences invests record £7.6m into early-career biomedical researchers

April 7, 2025 Research and Development Academy of Medical Sciences, British Heart Foundation, Corporate, Wellcome, biomedical research, funding

The Academy of Medical Sciences has awarded £7.6m to support 62 early-career biomedical researchers across the UK, marking the largest …
News

European consortium launches project to advance alpha-emitting radiotherapies

April 7, 2025 Research and Development Akiram Therapeutics, European Consortium, Oncology, PreTT, TetraKit Technologies, radiotherapy

A new European research initiative PRE-CISE has been launched with the aim of developing next-generation targeted alpha-therapies for cancer treatment. …
News

New hormonal treatment launched to help prevent miscarriage in early pregnancy

April 4, 2025 Research and Development Besins Healthcare, Reproductive health, hormonal therapy, miscarriage, pregnancy

A new progesterone-based treatment aimed at preventing miscarriage has been launched across the UK, following a major clinical trial that …
News

Bristol Myers Squibb receives positive CHMP opinion for Opdivo treatment

April 4, 2025 Research and Development CHMP, Oncology, bristol myers squibb, immunotherapy, lung cancer, opdivo

Bristol Myers Squibb (BMS) has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for …
News
handshake_2

Curium Pharma announces acquisition of Monrol

April 3, 2025 Manufacturing and Production, Research and Development Curium Pharma, Monrol, Oncology, acquisition, nuclear medicine, radiopharmaceutical products

Curium Pharma, a nuclear medicine company, has acquired Eczacıbaşı-Monrol Nuclear Products (Monrol), a nuclear medicine player. With facilities across Europe …
News

GRI Bio announces two global patents granted for Europe and Japan

April 2, 2025 Research and Development Chronic Diseases, GRI Bio, autoimmune diseases, biotech, fibrotic diseases, inflammatory diseases, patent

GRI Bio, a biotech company that specialises in treatment for inflammatory, fibrotic and autoimmune diseases, has announced that two global …
News

Usama Dar appointed as chief product and technology officer at CluePoints

April 2, 2025 Research and Development Pharmacy, clinical trial analysis, cluepoints, pharma, research and development

CluePoints has appointed Usama Dar as its new chief product and technology officer, effective 1 April 2025. This follows Dar’s …
Appointment

Dupixent approved as first biologic medicine in Japan for COPD patients

April 2, 2025 Research and Development COPD, Chronic Diseases, Regeneron, Sanofi, biotech, respiratory disease

The Ministry of Health, Labour and Welfare in Japan has authorised marketing and manufacturing of Dupixent (dupilumab) for the treatment …
News

Rybelsus found to reduce major adverse cardiovascular events in Novo Nordisk trial

April 1, 2025 Research and Development Cardiology, Novo Nordisk, cardiometabolic diseases, research and development

Novo Nordisk announced results from its SOUL cardiovascular outcomes trial. Rybelsus (oral semaglutide) significantly reduced the risk of major adverse …
News

Corcept’s relacorilant trial in patients with platinum-resistant ovarian cancer meets primary endpoint

April 1, 2025 Research and Development Corcept Therapeutics, Oncology, ovarian cancer, research and development

Corcept Therapeutics announced that relacorilant plus nab-paclitaxel met its primary endpoint of improved progression-free survival in ROSELLA, the company’s phase …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025